SANGIOLO, Dario
 Distribuzione geografica
Continente #
NA - Nord America 3.274
EU - Europa 1.485
AS - Asia 980
SA - Sud America 57
AF - Africa 48
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 7
Totale 5.891
Nazione #
US - Stati Uniti d'America 3.178
IT - Italia 611
CN - Cina 464
DE - Germania 194
FR - Francia 169
GB - Regno Unito 129
CA - Canada 87
VN - Vietnam 86
IN - India 84
JP - Giappone 67
KR - Corea 51
PL - Polonia 50
NL - Olanda 41
HK - Hong Kong 38
CZ - Repubblica Ceca 35
TW - Taiwan 34
AU - Australia 33
PH - Filippine 33
TR - Turchia 32
ES - Italia 31
IE - Irlanda 30
ZA - Sudafrica 29
RU - Federazione Russa 27
BR - Brasile 23
BE - Belgio 20
TH - Thailandia 20
UA - Ucraina 19
CH - Svizzera 18
IL - Israele 16
RO - Romania 15
CL - Cile 14
IR - Iran 13
PT - Portogallo 13
SG - Singapore 12
EG - Egitto 11
SE - Svezia 11
MK - Macedonia 10
CO - Colombia 9
FI - Finlandia 9
ID - Indonesia 9
AT - Austria 8
GR - Grecia 8
DK - Danimarca 7
HU - Ungheria 7
NZ - Nuova Zelanda 7
AE - Emirati Arabi Uniti 6
MX - Messico 6
NO - Norvegia 6
LT - Lituania 5
RS - Serbia 5
AR - Argentina 4
KE - Kenya 4
MY - Malesia 4
SA - Arabia Saudita 4
PE - Perù 3
PK - Pakistan 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
AP - ???statistics.table.value.countryCode.AP??? 2
BY - Bielorussia 2
EC - Ecuador 2
HR - Croazia 2
NG - Nigeria 2
UY - Uruguay 2
BF - Burkina Faso 1
BT - Bhutan 1
CR - Costa Rica 1
EU - Europa 1
HN - Honduras 1
JO - Giordania 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
PA - Panama 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 5.891
Città #
Fairfield 378
Houston 261
Ashburn 236
Santa Cruz 204
Woodbridge 181
Seattle 163
Buffalo 160
Ann Arbor 147
Torino 116
Cambridge 114
Wilmington 90
Beijing 83
Shanghai 66
Dong Ket 60
Turin 46
Pisa 42
Wuhan 42
Milan 41
Warsaw 41
Los Angeles 37
University Park 37
San Diego 34
Chicago 33
Las Vegas 32
Dublin 30
Ottawa 28
Mountain View 26
Boardman 24
Rovello Porro 24
Taipei 23
Muizenberg 21
New York 21
Guangzhou 20
Nanjing 20
Clearwater 19
Dallas 19
Seoul 19
Munich 18
San Jose 16
Phoenix 15
Rome 15
Changsha 14
London 14
Montréal 14
Arezzo 13
Chengdu 13
Henderson 13
Riva 13
Toronto 13
San Francisco 12
Lake Forest 11
Scranton 11
Xian 11
Bangkok 10
Hangzhou 10
Carrara 9
Central 9
Des Moines 9
Hefei 9
Istanbul 9
Liberty 9
Singapore 9
Bangalore 8
Bengaluru 8
Council Bluffs 8
Edinburgh 8
Mcallen 8
Norwalk 8
Nürnberg 8
Portland 8
Redmond 8
Ankara 7
Collegeville 7
Dearborn 7
Fleming Island 7
Frankfurt am Main 7
Gent 7
Johannesburg 7
Yellow Springs 7
Boston 6
Esslingen 6
Helsinki 6
Provo 6
Shenyang 6
Sydney 6
Tianjin 6
Tokyo 6
Absecon 5
Amsterdam 5
Austin 5
Cheyenne 5
Columbus 5
Easton 5
Falkenstein 5
Florence 5
Hanoi 5
Jacksonville 5
Jakarta 5
Luni 5
Madrid 5
Totale 3.478
Nome #
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial, file e27ce427-00c2-2581-e053-d805fe0acbaa 645
Complete Resolution of Life-Threatening Bleomycin-Induced Pneumonitis After Treatment With Imatinib Mesylate in a Patient With Hodgkin's Lymphoma: Hope for Severe Chemotherapy-Induced Toxicity?, file e27ce426-d991-2581-e053-d805fe0acbaa 534
Cytokine Induced Killer cells kill chemo-surviving melanoma cancer stem cells, file e27ce42a-9b95-2581-e053-d805fe0acbaa 342
NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives, file e27ce42e-0939-2581-e053-d805fe0acbaa 308
Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectives, file e27ce428-b16f-2581-e053-d805fe0acbaa 297
Post-Transplant Cyclophosphamide and Tacrolimus–Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors, file e27ce42d-231f-2581-e053-d805fe0acbaa 195
Next generation immune-checkpoints for cancer therapy, file e27ce42c-c704-2581-e053-d805fe0acbaa 194
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition, file e27ce42b-2f9c-2581-e053-d805fe0acbaa 188
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models, file e27ce42b-7361-2581-e053-d805fe0acbaa 180
BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody, file e27ce42c-bad0-2581-e053-d805fe0acbaa 179
Genetically Redirected T Lymphocytes for Adoptive Immunotherapy of Solid Tumors., file e27ce426-fc47-2581-e053-d805fe0acbaa 169
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells, file e27ce42c-d51b-2581-e053-d805fe0acbaa 160
Activity of cytokine-induced killer cells against bone and soft tissue sarcoma., file e27ce426-f597-2581-e053-d805fe0acbaa 158
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy, file e27ce42d-a39a-2581-e053-d805fe0acbaa 157
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity, file e27ce429-5269-2581-e053-d805fe0acbaa 152
Recent advances in the development of breast cancer vaccines., file e27ce427-0b7e-2581-e053-d805fe0acbaa 150
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma, file e27ce427-55f6-2581-e053-d805fe0acbaa 140
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways, file e27ce42d-e185-2581-e053-d805fe0acbaa 137
Adoptive immunotherapy against ovarian cancer, file e27ce429-4f51-2581-e053-d805fe0acbaa 127
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group, file e27ce433-cdb4-2581-e053-d805fe0acbaa 125
Cytokine Induced Killer cells effectively kill chemo-resistant melanoma cancer stem cells., file e27ce427-0f8d-2581-e053-d805fe0acbaa 115
Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective., file e27ce426-efb2-2581-e053-d805fe0acbaa 114
The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societies, file e27ce434-4122-2581-e053-d805fe0acbaa 110
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes, file e27ce430-b2f1-2581-e053-d805fe0acbaa 105
Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma, file e27ce42c-d6c3-2581-e053-d805fe0acbaa 104
CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy, file e27ce42e-0aba-2581-e053-d805fe0acbaa 92
Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer, file e27ce430-12da-2581-e053-d805fe0acbaa 87
Pazopanib and trametinib as a synergistic strategy against osteosarcoma: Preclinical activity and molecular insights, file e27ce42f-e4dc-2581-e053-d805fe0acbaa 84
Cytokine profiling of end stage cancer patients treated with immunotherapy, file e27ce431-f48a-2581-e053-d805fe0acbaa 67
Recruitment, infiltration and cytotoxicity of hla-independent killer lymphocytes in three-dimensional melanoma models, file e27ce431-cd88-2581-e053-d805fe0acbaa 66
Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy, file e27ce426-f9a7-2581-e053-d805fe0acbaa 56
Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective, file e27ce431-d0ac-2581-e053-d805fe0acbaa 56
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors, file e27ce432-03f2-2581-e053-d805fe0acbaa 50
Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review, file e27ce434-49a5-2581-e053-d805fe0acbaa 44
Parp1 inhibitor and trabectedin combination does not increase tumor mutational burden in advanced sarcomas—a preclinical and translational study, file e27ce434-7d1c-2581-e053-d805fe0acbaa 43
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas., file e27ce426-fc4a-2581-e053-d805fe0acbaa 41
Immunotherapy associated pulmonary toxicity: Biology behind clinical and radiological features, file e27ce434-4ae7-2581-e053-d805fe0acbaa 37
Novel lymphocyte-independent antitumor activity by PD-1 blocking antibody against PD-1+ chemoresistant lung cancer cells, file 68f37efa-f34e-4e08-8b01-b1921586362f 34
Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma, file e27ce434-4a0c-2581-e053-d805fe0acbaa 30
Redirectedt cells in cancer therapy, file e27ce434-4ae9-2581-e053-d805fe0acbaa 28
Significance of TIM3 expression in cancer: From biology to the clinic, file 1c583001-a1fa-4049-8b38-529125db02fa 27
Cytokine Induced Killer cells effectively kill chemo-resistant melanoma cancer stem cells., file e27ce427-0f8e-2581-e053-d805fe0acbaa 20
Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours, file e27ce432-5cb3-2581-e053-d805fe0acbaa 18
Fibroblasts Impair Migration and Antitumor Activity of NK-92 Lymphocytes in a Melanoma-on-Chip Model, file 7ddbf793-c04a-4820-aaa8-8d835e5addc6 16
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriers, file f00758c0-2499-463a-8fb2-6d2bebb49288 16
Dual VEGFA/BRAF targeting boosts PD-1 blockade in melanoma through GM-CSF-mediated infiltration of M1 macrophages, file 0f7b36ae-8da4-4965-9703-76f0c210267c 15
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination, file 2ffec199-1478-4bf3-9443-bc395c5485aa 14
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study, file e3009967-8951-4d63-ac33-d2369dd472c6 14
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer, file da5de55f-f3c4-4f0c-9ea1-6482648974b4 12
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy, file 505c7d60-5416-4cc6-b7df-52d88f6410fe 11
Role of interferon in melanoma: old hopes and new perspectives, file e27ce42d-3bfb-2581-e053-d805fe0acbaa 10
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group, file e27ce42d-50ca-2581-e053-d805fe0acbaa 10
Veliparib: a new therapeutic option in ovarian cancer?, file e27ce42e-2c92-2581-e053-d805fe0acbaa 8
Cytokine-induced killer cells as immunotherapy for solid tumors: current evidences and perspectives, file e27ce430-1402-2581-e053-d805fe0acbaa 8
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST, file 69ddea7c-dc59-446c-bde7-e9bd7e699410 6
Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19, file ef985fbf-12fb-4dac-be53-c2ed5c96101b 5
Genetically Redirected T Lymphocytes for Adoptive Immunotherapy of Solid Tumors., file e27ce426-fc48-2581-e053-d805fe0acbaa 4
Adoptive immunotherapy against sarcomas., file e27ce427-00c4-2581-e053-d805fe0acbaa 4
Treating breast cancer with cell-based approaches: an overview, file e27ce42d-b22a-2581-e053-d805fe0acbaa 4
The Combination of Sorafenib and Everolimus abrogates mTORC-1 and mTORC2 up-regulation in preclinical models of Osteosarcoma., file 7c10a454-80d9-42d2-9372-32954969826e 3
Cytokine induced killer cells as promising immunotherapy for solid tumors, file af291c74-0f10-48d2-a6ef-977661ed6e72 3
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors., file e27ce426-d2db-2581-e053-d805fe0acbaa 3
Activity of cytokine-induced killer cells against bone and soft tissue sarcoma., file e27ce426-f598-2581-e053-d805fe0acbaa 3
Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour, file e27ce42d-2e7c-2581-e053-d805fe0acbaa 3
Survivin-peptide vaccination elicits immune response after allogeneic nonmyeloablative transplantation: a safe strategy to enhance the graft versus tumor effect, file e27ce42e-7b6d-2581-e053-d805fe0acbaa 3
Platinum-based chemotherapy attenuates the effector response of CD8 T cells to concomitant PD-1 blockade, file 18a1cde9-5f99-4de8-81c4-15fa29c9c352 2
Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets, file 40123cf0-ea09-4e27-a689-b71d040e9377 2
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma, file 8ee0a396-fff6-4abf-b23f-ba81cb866a42 2
Efficient transcriptional targeting of human hematopoietic stem cells and blood cell lineages by lentiviral vectors containing the regulatory element of the Wiskott-Aldrich Syndrome gene, file e27ce426-b4f4-2581-e053-d805fe0acbaa 2
Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers., file e27ce426-e7f5-2581-e053-d805fe0acbaa 2
Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective., file e27ce426-efb1-2581-e053-d805fe0acbaa 2
Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy, file e27ce426-f9a6-2581-e053-d805fe0acbaa 2
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas., file e27ce426-fc49-2581-e053-d805fe0acbaa 2
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial, file e27ce427-00c3-2581-e053-d805fe0acbaa 2
PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpoint blockade, file 6a93eeca-f086-4e63-a472-dbac754d5127 1
Cytokine Induced Killer cells kill chemo-surviving melanoma cancer stem cells, file e27ce432-47f9-2581-e053-d805fe0acbaa 1
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial, file e27ce432-4f99-2581-e053-d805fe0acbaa 1
Treatment of metastatic melanoma: a multidisciplinary approach, file e27ce432-60b3-2581-e053-d805fe0acbaa 1
Totale 6.162
Categoria #
all - tutte 9.554
article - articoli 0
book - libri 0
conference - conferenze 375
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.929


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019353 0 0 0 0 0 0 0 0 0 79 167 107
2019/20201.178 86 89 57 149 77 66 84 125 128 130 98 89
2020/20211.130 92 98 74 107 89 86 78 78 84 127 94 123
2021/20221.348 129 134 63 126 107 42 94 88 101 86 282 96
2022/20231.025 44 69 233 138 93 77 104 49 65 50 88 15
2023/2024339 13 24 40 31 33 28 83 59 16 12 0 0
Totale 6.162